FENNEC PHARMACEUTICALS INC. Current Assets
FENNEC PHARMACEUTICALS INC. (FENC) had Current Assets of $72.50 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $72.50M.
- 2026-03-31: Assets, Current $66.88M.
- 2025-12-31: Assets, Current $67.04M.
- 2025-09-30: Assets, Current $46.06M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $72.50M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $66.88M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $67.04M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $46.06M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $40.79M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $42.98M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $44.12M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $57.97M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $62.17M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $68.17M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $26.86M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $19.90M 10-K · filed 2024-03-29 | $18.95M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $19.33M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $21.66M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $26.73M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $30.15M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $15.55M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $19.13M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $22.39M 10-K · filed 2023-03-29 | |
| 2021-06-30 | $28.07M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $27.82M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $31.42M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $34.07M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $38.90M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $10.12M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $13.88M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $15.63M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $17.53M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $20.34M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $22.95M 10-K · filed 2020-02-14 | |
| 2018-09-30 | $24.93M 10-Q · filed 2018-11-13 | |
| 2017-12-31 | $28.40M 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |